Literature DB >> 12436411

The nicotinic receptor ligand binding domain.

Steven M Sine1.   

Abstract

The ligand binding domain (LBD) of the nicotinic acetylcholine receptor has served as a prototype for understanding molecular recognition in the family of neurotransmitter-gated ion channels. During the past fifty years, studies progressed from fundamental electrophysiological analyses of ACh-evoked ion flow, to biochemical purification of the receptor protein, pharmacological measurements of ligand binding, molecular cloning of receptor subunits, site-directed mutagenesis combined with functional analysis and recently, atomic structural determination. The emerging picture of the nicotinic receptor LBD is a specialized pocket of aromatic and hydrophobic residues formed at interfaces between protein subunits that changes conformation to convert agonist binding into gating of an intrinsic ion channel. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12436411     DOI: 10.1002/neu.10139

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  61 in total

1.  Asymmetric structural motions of the homomeric alpha7 nicotinic receptor ligand binding domain revealed by molecular dynamics simulation.

Authors:  Richard H Henchman; Hai-Long Wang; Steven M Sine; Palmer Taylor; J Andrew McCammon
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

2.  Structural and ligand recognition characteristics of an acetylcholine-binding protein from Aplysia californica.

Authors:  Scott B Hansen; Todd T Talley; Zoran Radic; Palmer Taylor
Journal:  J Biol Chem       Date:  2004-04-06       Impact factor: 5.157

3.  Myasthenic syndrome AChRα C-loop mutant disrupts initiation of channel gating.

Authors:  Xin-Ming Shen; Joan M Brengman; Steven M Sine; Andrew G Engel
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

4.  A gating mechanism proposed from a simulation of a human alpha7 nicotinic acetylcholine receptor.

Authors:  Richard J Law; Richard H Henchman; J Andrew McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-27       Impact factor: 11.205

5.  Acetylcholine nicotinic receptors: finding the putative binding site of allosteric modulators using the "blind docking" approach.

Authors:  Bogdan Iorga; Denyse Herlem; Elvina Barré; Catherine Guillou
Journal:  J Mol Model       Date:  2005-12-22       Impact factor: 1.810

6.  Number and locations of agonist binding sites required to activate homomeric Cys-loop receptors.

Authors:  Diego Rayes; María José De Rosa; Steven M Sine; Cecilia Bouzat
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

Review 7.  Muscle relaxant use during intraoperative neurophysiologic monitoring.

Authors:  Tod B Sloan
Journal:  J Clin Monit Comput       Date:  2012-09-27       Impact factor: 2.502

8.  Functional polymorphisms in the human beta4 subunit of nicotinic acetylcholine receptors.

Authors:  Yong Liang; Ramiro Salas; Lisa Marubio; Dani Bercovich; Mariella De Biasi; Arthur L Beaudet; John A Dani
Journal:  Neurogenetics       Date:  2004-11-25       Impact factor: 2.660

9.  Morantel allosterically enhances channel gating of neuronal nicotinic acetylcholine alpha 3 beta 2 receptors.

Authors:  Tse-Yu Wu; Caleb M Smith; Steven M Sine; Mark M Levandoski
Journal:  Mol Pharmacol       Date:  2008-05-05       Impact factor: 4.436

10.  The role of loop 5 in acetylcholine receptor channel gating.

Authors:  Sudha Chakrapani; Timothy D Bailey; Anthony Auerbach
Journal:  J Gen Physiol       Date:  2003-10-13       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.